The CSL (ASX:CSL) share price is falling today, but here's what investors can look forward to next week

CSL shares are losing steam today, but the company has a big event coming up…

Sebastian Bowen

Author Bio Sebastian Bowen has been a Motley Fool contributor since late 2018. Sebastian found his passion for writing and educating others about shares and all things finance after completing his studies in political, economic and social science and enjoys bringing this passion to life at the Fool. His investment philosophy is a simple one – buying high-quality companies at prices that make sense. When he’s not researching his next investment at all hours of the morning, Sebastian enjoys classic movies and likes to unwind with a good book, newspaper or record. Areas of Expertise Dividend investing ETFs Education Bachelor of Political, Economic, and Social Sciences (Government and International Relations), University of Sydney Social Media X/Twitter Favorite Investment Quote "In the short run, the market is a voting machine, but in the long run, it is a weighing machine." – Benjamin Graham

Published March 4, 2022 12:01 pm AEDT

It hasn't been a very pleasant day for the CSL Limited (ASX: CSL) share price so far today. Or the S&P/ASX 200 Index (ASX: XJO) for that matter. At the time of writing, the ASX 200 has fallen by 1.36% and is back under 7,100 points. As it currently stands, CSL shares are trading at $254.83 each, down 1.04% so far today.

it appears the announcement that CSL made last night hasn't been enough to buck the trend of the broader market. Although, it's worth saying that perhaps it has been enough to give the healthcare giant a slight edge over the ASX 200.

As my Fool colleague James covered this morning, CSL has announced an update regarding its major acquisition plans. Back in December last year, CSL announced it was intending to acquire the Swiss biotech company Vifor Pharma for US$12.3 billion in cash. Well, we got an update on this proposed buyout after market close yesterday.

CSL revealed that 74% of Vifor shares have been tendered as part of its public tender offer. Originally, the deal had an 80% target. However, CSL has decided to waive this requirement and will be pressing ahead with the deal. It still plans to have the acquisition cross the finish line by mid-2022.

So perhaps this development is having an impact on the CSL share price so far this Friday.

A doctor appears shocked as he looks through binoculars on a blue background. — Image source: Getty Images

CSL shares to pay out next month

But there is also a big event for CSL coming up next week.

Monday will see this healthcare share trade ex-dividend for its upcoming interim dividend payment. This dividend was announced when the company delivered its half-year earnings results last month. The dividend investors are to receive will be a US$1.04 payment, which will be worth approximately A$1.42 per share going off current exchange rates. The raw US$1.04 payment is flat on last year's interim dividend. It will come unfranked.

So today is effectively the last day that investors can buy CSL shares if they want to receive this dividend. Come Monday, any new investors will be ineligible, and as such, the value of this dividend will leave the CSL share price. So don't be surprised if we see a share price fall for CSL on Monday. But investors will have to wait until April 6 to see this dividend hit their bank accounts. Something to look forward to.

At the current CSL share price, this ASX 200 healthcare share has a market capitalisation of $123.27 billion, with a dividend yield of 1.02%

Automatic Renewal

By taking up this offer, you will also be enrolled in our auto-renewal program, which is our way of making your ongoing subscription easier by ensuring uninterrupted service. Don't worry, though – you're not locked in, and can cancel your auto-renewal at any time before each 'anniversary' date without question or penalty.